Effects of 5,6-dihydroxytryptamine and 5,7-dihydroxytryptamine on the rat central nervous system after intraventricular or intracerebral application and on blood platelets in vitro.
D015115:5,6-Dihydroxytryptamine / Q000008:administration & dosage / Q000494:pharmacology*; D015116:5,7-Dihydroxytryptamine / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D001679:Biogenic Amines / Q000378:metabolism; D001792:Blood Platelets / Q000187:drug effects* / Q000378:metabolism; D002490:Central Nervous System / Q000187:drug effects* / Q000378:metabolism; D004102:Dihydroxytryptamines / Q000494:pharmacology*; D004347:Drug Interactions; D005260:Female; D010134:Fenclonine / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D007276:Injections, Intraventricular; D008297:Male; D008474:Medial Forebrain Bundle; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D051381:Rats; D012399:Rotation; D012701:Serotonin / Q000097:blood; D012726:Sexual Behavior, Animal / Q000187:drug effects; D013239:Stereotyped Behavior / Q000187:drug effects
D001679:Biogenic Amines; D004102:Dihydroxytryptamines; D008996:Monoamine Oxidase Inhibitors; D015116:5,7-Dihydroxytryptamine; D012701:Serotonin; D010134:Fenclonine; D015115:5,6-Dihydroxytryptamine